GUANZE MEDICAL (02427)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| Moore & Assoc | 30-Jun-25 | |||
| Ernst & Young | 15-Dec-22 | 30-Jun-25 | A lower audit fee would allow the Company to implement more effective cost control measures and reduce overall operating expenses, which would benefit the Company and its shareholders as a whole. Following discussion between the Company and Ernst & Young regarding the proposed change of auditor, at the request of the Board, EY has agreed to resign as the Company’s auditor, effective from 30 June 2025. |